Clinical Trial Sponsors Urged To Post Study Design Details Ahead Of Results
This article was originally published in The Pink Sheet Daily
Executive Summary
Vermont Assistant Attorney General Brill says disclosure of clinical trial results on a central registry and posting of a study's design and endpoints before the results would suggest "true disclosure," not off-label marketing.
You may also be interested in...
PhRMA Clinical Trial Registry Will Be Launched Oct. 1
Clinicalstudyresults.org will include results of all controlled “hypothesis testing” clinical trials completed since October 2002 for PhRMA member companies’ marketed products. Postings will include a drug’s label, a bibliography of published studies, and summaries of unpublished studies.
GSK Settles With N.Y.; Company Will Post Past Trial Data By End Of 2005
The settlement includes a modest $2.5 mil. disgorgement fee. GSK is also required to advertise the clinical trial register in seven prominent peer reviewed journals.
HHS Should Track All Rx Clinical Trials, AMA Says
All trials should be registered to ensure results are publicly available, physicians’ association says. Institutional review boards should not approve trials unless they are registered, AMA policy urges.